Marshall Wace
RXRX icon

Marshall Wace’s Recursion Pharmaceuticals RXRX Stock Holding History

Marshall Wace’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.83M Buy
2,876,928
+2,650,319
+1,170% +$10.2M 0.01% 1036
2025
Q4 		$927K Buy
226,609
+148,350
+190% +$735K ﹤0.01% 1970
2025
Q3 		$382K Sell
78,259
-8,053
-9% -$42.3K ﹤0.01% 2334
2025
Q2 		$437K Sell
86,312
-247,300
-74% -$1.21M ﹤0.01% 2194
2025
Q1 		$1.76M Buy
+333,612
New +$2.43M ﹤0.01% 1520
2024
Q2 		– Sell
-391,518
Closed -$3.9M – 2940
2024
Q1 		$3.9M Buy
+391,518
New +$4.36M 0.01% 1098
2023
Q2 		– Sell
-514,137
Closed -$3.43M – 2969
2023
Q1 		$3.43M Buy
+514,137
New +$4.08M 0.01% 1178
2022
Q3 		– Sell
-106,786
Closed -$869K – 3815
2022
Q2 		$869K Buy
+106,786
New +$715K ﹤0.01% 2526

Other funds holding RXRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return